Print page Close print preview
Logo Going International
Accedi a banche dati online | Convegnodetail
 

2nd Next Generation Kinase Inhibitors Summit

Evvnt Promotion / evvnt
Archivio
-
22.02.2023 - 23.02.2023  Boston Park Plaza, 50 Park Plaza, 02116 Boston, USA
Time: 8:00 am to 6:00 pm
 
Temi della conferenza
With strong effectiveness profiles and 20 years of FDA approval, kinase inhibitors have revolutionized oncology treatment. The success of current kinase inhibitor classes is nevertheless constrained by rising resistance and security concerns.
Scientific organizer
Hanson Wade
Annotazioni
Speakers: Erik Schaefer, Co-Founder, President, Chief Executive Officer and Chief Scientific Officer, AssayQuant Technologies Inc., Gerhard Mueller, Chief Scientific Officer, Anavo Therapeutics, Harish Dave, Chief Medical Officer, AUM Biosciences
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1446853-3?pid=4832
Mr. Min Ratcliffe
 
Categorie
Sanità Pubblica (Public Health), Servizi sanitari
Lingua
Inglese
Quote del Congresso
Free: USD 0.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom